中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝孤立性纤维瘤1例报告

李学成 范莹 吴硕东

引用本文:
Citation:

肝孤立性纤维瘤1例报告

DOI: 10.3969/j.issn.1001-5256.2022.03.026
基金项目: 

沈阳市中青年科技创新人才支持计划 (RC200121)

伦理学声明:本例报告已获得患者知情同意。
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:李学成负责拟定写作思路,撰写论文; 范莹负责课题设计,指导撰写论文; 吴硕东负责指导撰写文章并最后定稿。
详细信息
    通信作者:

    范莹,coolingpine78@163.com

Solitary fibrous tumor of the liver: A case report

Research funding: 

Shenyang Youth Science and Technology Innovation Talents Support Program (RC200121)

More Information
  • 图  1  肝孤立性纤维瘤患者CT检查结果

    注:a,水平位; b,冠状位。可见肿瘤位于肝肾之间,与肝脏下缘关系密切,右肾受压,呈囊实混合性。

    图  2  病理学检查结果(HE染色,×40)

    图  3  免疫组化检查结果(Envision,×100)

    注:a,CD34(+); b,STAT6(+)。

  • [1] NAM HC, SUNG PS, JUNG ES, et al. Solitary fibrous tumor of the liver mimicking malignancy[J]. Korean J Intern Med, 2020, 35(3): 734-735. DOI: 10.3904/kjim.2018.442.
    [2] ANDALUZ GARCÍA I, TAVECCHIA M, OLVEIRA MARTÍN A. A solitary fibrous tumor: An entity to consider in the diagnosis of liver masses[J]. Rev Esp Enferm Dig, 2019, 111(12): 969. DOI: 10.17235/reed.2019.6433/2019.
    [3] ROUY M, GUILBAUD T, BIRNBAUM DJ. Liver solitary fibrous tumor: A rare incidentaloma[J]. J Gastrointest Surg, 2021, 25(3): 852-853. DOI: 10.1007/s11605-020-04701-8.
    [4] ALONSO BATANERO S, GARROSA MUÑOZ S, IGLESIAS IGLESIAS MJ, et al. A giant solitary fibrous tumor arising from the hepatic round ligament[J]. Dig Liver Dis, 2021, 53(3): 379-380. DOI: 10.1016/j.dld.2020.06.015.
    [5] DU Y, YAN YH, XIAO JS, et al. Giant right hepatic benign fibroma: A case report and literature review[J]. Chin J Hepatobiliary Surg, 2019, 25(9): 701-702. DOI: 10.3760/cma.j.issn.1007-8118.2019.09.016.

    杜源, 鄢业鸿, 肖建生, 等. 右肝巨大纤维瘤一例并文献复习[J]. 中华肝胆外科杂志, 2019, 25(9): 701-702. DOI: 10.3760/cma.j.issn.1007-8118.2019.09.016.
    [6] MU YP, WANG RT, HOU HL, et al. Clinicopathological characteristics and surgical effcacy of liver solitary fibrous tumor and literature review[J/CD]. Chin J Hepat Surg (Electronic Edition), 2021, 10(1): 87-92. DOI: 10.3877/cma.j.issn.2095-3232.2021.01.019.

    牟怡平, 王瑞涛, 侯惠莲, 等. 肝脏孤立性纤维瘤临床病理特征及手术疗效并文献复习[J/CD]. 中华肝脏外科手术学电子杂志, 2021, 10(1): 87-92. DOI: 10.3877/cma.j.issn.2095-3232.2021.01.019.
    [7] FAMÀ F, LE BOUC Y, BARRANDE G, et al. Solitary fibrous tumour of the liver with IGF-Ⅱ-related hypoglycaemia. A case report[J]. Langenbecks Arch Surg, 2008, 393(4): 611-616. DOI: 10.1007/s00423-008-0329-z.
    [8] VENNARECCI G, ETTORRE GM, GIOVANNELLI L, et al. Solitary fibrous tumor of the liver[J]. J Hepatobiliary Pancreat Surg, 2005, 12(4): 341-344. DOI: 10.1007/s00534-005-0993-0.
    [9] DELVECCHIO A, DUDA L, CONTICCHIO M, et al. Doege-Potter syndrome by malignant solitary fibrous tumor of the liver: A case report and review of literature[J]. World J Gastrointest Surg, 2019, 11(8): 348-357. DOI: 10.4240/wjgs.v11.i8.348.
    [10] SONG L, ZHANG W, ZHANG Y. (18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor[J]. Clin Nucl Med, 2014, 39(7): 662-664. DOI: 10.1097/RLU.0000000000000431.
    [11] DOYLE LA, VIVERO M, FLETCHER CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics[J]. Mod Pathol, 2014, 27(3): 390-395. DOI: 10.1038/modpathol.2013.164.
    [12] YOSHIDA A, TSUTA K, OHNO M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors[J]. Am J Surg Pathol, 2014, 38(4): 552-559. DOI: 10.1097/PAS.0000000000000137.
    [13] DEMICCO EG, HARMS PW, PATEL RM, et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors[J]. Am J Clin Pathol, 2015, 143(5): 672-682. DOI: 10.1309/AJCPN25NJTOUNPNF.
    [14] O'NEILL AC, TIRUMANI SH, DO WS, et al. Metastatic patterns of solitary fibrous tumors: A single-institution experience[J]. AJR Am J Roentgenol, 2017, 208(1): 2-9. DOI: 10.2214/AJR.16.16662.
    [15] EBATA T, SHIMOI T, BUN S, et al. Efficacy and safety of pazopanib for recurrent or metastatic solitary fibrous tumor[J]. Oncology, 2018, 94(6): 340-344. DOI: 10.1159/000486623.
    [16] MARUZZO M, MARTIN-LIBERAL J, MESSIOU C, et al. Pazopanib as first line treatment for solitary fibrous tumours: The Royal Marsden Hospital experience[J]. Clin Sarcoma Res, 2015, 5: 5. DOI: 10.1186/s13569-015-0022-2.
    [17] STACCHIOTTI S, TORTORETO M, BALDI GG, et al. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour[J]. Eur J Cancer, 2014, 50(17): 3021-3028. DOI: 10.1016/j.ejca.2014.09.004.
  • 加载中
图(3)
计量
  • 文章访问数:  250
  • HTML全文浏览量:  113
  • PDF下载量:  45
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-30
  • 录用日期:  2021-08-06
  • 出版日期:  2022-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回